Jason Raleigh Nunn

CIK 1444319 · last filed 2025-10-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$23.27M

Companies

6

Total Filings

41

Lifetime Open-Market Net

$16.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZBIO Director 1,173,395 $19.80 $23.23M $16.20M 3 2025-10-14
Regulus Therapeutics Inc. (RGLS) Delisted Director 0 $8.16 $0 $0 10 2025-06-27
TRVN Director 4,271 $0.01 $47 $0 11 2024-06-14
DERM Director 6,000 $6.34 $38.0K $0 7 2019-06-14
TriVascular Technologies, Inc. (TRIV) Delisted Director $0 1 2015-05-27
HYPERION THERAPEUTICS INC (HPTX) Delisted Director $0 1 2013-05-01

Recent Filings · Page 3 of 5

41 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-06-06 DERM Grant (A) $0 EDGAR
2019-05-16 TRVN Grant (A) $0 EDGAR
2018-06-14 DERM Mixed +3,000 $0 EDGAR
2018-05-17 TRVN Grant (A) $0 EDGAR
2017-06-15 DERM Grant (A) $0 EDGAR
2017-06-06 TRVN Grant (A) $0 EDGAR
2016-06-30 DERM Grant (A) $0 EDGAR
2016-06-23 DERM Grant (A) $0 EDGAR
2016-05-19 TRVN Grant (A) $0 EDGAR
2015-12-10 TRVN Other (J) +4,271 $0 EDGAR
Showing 2130 of 41
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.